Synthetic mRNA capping

Scholarly Works

• Shariati, A.; Khani, P.; Nasri, F.; Afkhami, H.; Khezrpour, A.; Kamrani, S.; Shariati, F.; Alavimanesh, S.; Modarressi, M. H. mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy. Biomarker research 2024, 12, 157. doi:10.1186/s40364-024-00692-9
• Abe, H.; Kimura, Y.; Honma, M.; Nakamoto, K.; Motosawa, K.; Atago, T.; Asano, K.; Hashiya, F.; Abe, N.; Kobayashi, K.; Ogisu, R.; Hashimoto, A.; Hiraishi, K.; Saito, S.; Yamamoto, J.; Iwai, H. Position-Specific Nucleoside Sugar Modifications in mRNA ORF: Enhancing Translational Function through Complete Chemical Synthesis of mRNA. Springer Science and Business Media LLC 2024. doi:10.21203/rs.3.rs-4312265/v1
• Drążkowska, K.; Tomecki, R.; Tudek, A. Purification of Enzymatically Active Xrn1 for Removal of Non-capped mRNAs from In Vitro Transcription Reactions and Evaluation of mRNA Decapping Status In Vivo. Methods in molecular biology (Clifton, N.J.) 2024, 2863, 81–105. doi:10.1007/978-1-0716-4176-7_7
• Ripp, A.; Krämer, M.; Barth, V.; Moser, P.; Haas, T. M.; Singh, J.; Huck, T.; Gleue, L.; Friedland, K.; Helm, M.; Jessen, H. J. The P(III)‐Amidite Based Synthesis of Stable Isotope Labeled mRNA‐Cap‐Structures Enables their Sensitive Quantitation from Brain Tissue. Angewandte Chemie 2024. doi:10.1002/ange.202414537
• Kumar, D.; Singh, A.; Kaviraj, S.; Singh, S. Unveiling Fundamentals and Research Opportunities of mRNA Technology. Biotechnology in India - Reworking A Strategy; Springer Nature Singapore, 2024; pp 113–146. doi:10.1007/978-981-97-0896-3_5
• Karimi-Sani, I.; Molavi, Z.; Naderi, S.; Mirmajidi, S.-H.; Zare, I.; Naeimzadeh, Y.; Mansouri, A.; Tajbakhsh, A.; Savardashtaki, A.; Sahebkar, A. Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials. Journal of nanobiotechnology 2024, 22, 601. doi:10.1186/s12951-024-02882-x
• Ripp, A.; Krämer, M.; Barth, V.; Moser, P.; Haas, T. M.; Singh, J.; Huck, T.; Gleue, L.; Friedland, K.; Helm, M.; Jessen, H. J. The P(III)-Amidite Based Synthesis of Stable Isotope Labeled mRNA-Cap-Structures Enables their Sensitive Quantitation from Brain Tissue. Angewandte Chemie (International ed. in English) 2024, e202414537. doi:10.1002/anie.202414537
• Rothweiler, U.; Gundesø, S. E.; Mikalsen, E. W.; Svenning, S.; Singh, M.; Combes, F.; Pettersson, F. J.; Mangold, A.; Piotrowski, Y.; Schwab, F.; Lanes, O.; Striberny, B. K. Using nucleolytic toxins as restriction enzymes enables new RNA applications. Nucleic acids research 2024, 52, e90. doi:10.1093/nar/gkae779
• Bartosik, K.; Micura, R. Access to capped RNAs by chemical ligation. RSC chemical biology 2024, 5, 1104–1110. doi:10.1039/d4cb00165f
• Hou, X.; Shi, J.; Xiao, Y. mRNA medicine: Recent progresses in chemical modification, design, and engineering. Nano Research 2024, 17, 9015–9030. doi:10.1007/s12274-024-6978-6
• Phan, T.; Fan, D.; Melstrom, L. G. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations. Current oncology (Toronto, Ont.) 2024, 31, 4855–4884. doi:10.3390/curroncol31090361
• Xing, L.; Wang, Z.-K.; Li, D.-M.; Li, J.; Liu, M. RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives. Hepatoma Research 2024. doi:10.20517/2394-5079.2024.25
• Narasipura, E. A.; Fenton, O. S. Advances in non-viral mRNA delivery to the spleen. Biomaterials science 2024, 12, 3027–3044. doi:10.1039/d4bm00038b
• Jolly, K. J.; Zhang, F. IVT-mRNA reprogramming of myeloid cells for cancer immunotherapy. Advances in pharmacology (San Diego, Calif.) 2024, 100, 247–288. doi:10.1016/bs.apha.2024.04.004
• Song, J.; Zhang, Y.; Zhou, C.; Zhan, J.; Cheng, X.; Huang, H.; Mao, S.; Zong, Z. The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy. International immunopharmacology 2024, 132, 112037. doi:10.1016/j.intimp.2024.112037
• Mahony, T. J.; Briody, T. E.; Ommeh, S. C. Can the Revolution in mRNA-Based Vaccine Technologies Solve the Intractable Health Issues of Current Ruminant Production Systems?. Vaccines 2024, 12, 152. doi:10.3390/vaccines12020152
• Oude Blenke, E.; Schiffelers, R. M.; Mastrobattista, E. Oligonucleotides and mRNA Therapeutics. Pharmaceutical Biotechnology; Springer International Publishing, 2024; pp 291–321. doi:10.1007/978-3-031-30023-3_13
• Sharma, P.; Hoorn, D.; Aitha, A.; Breier, D.; Peer, D. The immunostimulatory nature of mRNA lipid nanoparticles. Advanced drug delivery reviews 2024, 205, 115175. doi:10.1016/j.addr.2023.115175
• Pan, S.; Fan, R.; Han, B.; Tong, A.; Guo, G. The potential of mRNA vaccines in cancer nanomedicine and immunotherapy. Trends in immunology 2023, 45, 20–31. doi:10.1016/j.it.2023.11.003
• Inagaki, M. Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine. Journal of developmental biology 2023, 12, 1. doi:10.3390/jdb12010001

Explore citations to this article at